Export

EN
FR
Potassium chloride
Essential medicine status
Section:
26. Solutions correcting water, electrolyte and acid–base disturbances 26.2. Solutions correcting water, electrolyte and acid-base disturbances > Parenteral
ATC codes: B05XA01
EMLc
Indication
Hypokalaemia ICD11 code: 5C57
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Formulations
Parenteral > General injections > IV: 11.2% in 20 mL ampoule (equivalent to K+ 1.5 mmol/mL and Cl- 1.5 mmol/mL) (EML) ; 7.5% solution for dilution (equivalent to K+ 1 mmol/mL and Cl- 2 mmol/mL) (EMLc) ; 15% solution for dilution (equivalent to K+ 2 mmol/mL and Cl- 2 mmol/mL) (EMLc)
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 1989 (TRS 796)
Changed in 1991 (TRS 825)
Changed in 2007 (TRS 950)
Changed in 2009 (TRS 958)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Potassium chloride
DrugBank
Potassium chloride
Summary of evidence and Expert Committee recommendations
The EMLc Subcommittee recommended the addtition of two new strengths of potassium chloride IV solution for dilution (7.5% and 15%). The Subcommittee also recommended the deletion of the 11.2% strength from the EMLc. It remains listed on the EML.